Anticorps Monoclonal anti-TRAIL/CD253

TRAIL/CD253 Monoclonal Antibody for WB, IHC, Cytometric bead array, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

WB, IHC, Cytometric bead array, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1B9B4

N° de cat : 66756-1-PBS

Synonymes

TNFSF10, TRAIL, 1B9B4, Apo-2 ligand, CD253

---

Galerie de données de validation

• 

  WB analysis of human milk using 66756-1-Ig (same clone as 66756-1-PBS)

  human milk were subjected to SDS PAGE followed by western blot with 66756-1-Ig (TRAIL antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 66756-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human tonsillitis using 66756-1-Ig (same clone as 66756-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human tonsillitis tissue slide using 66756-1-Ig (TRAIL antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 66756-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human tonsillitis using 66756-1-Ig (same clone as 66756-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human tonsillitis tissue slide using 66756-1-Ig (TRAIL antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 66756-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human prostate cancer using 66756-1-Ig (same clone as 66756-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human prostate cancer tissue slide using 66756-1-Ig (TRAIL antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 66756-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human prostate cancer using 66756-1-Ig (same clone as 66756-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human prostate cancer tissue slide using 66756-1-Ig (TRAIL antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 66756-1-PBS in a different storage buffer formulation.

• 

  Cytometric bead array standard curve of MP50341-1

  Cytometric bead array standard curve of MP50341-1, TRAIL Monoclonal Matched Antibody Pair, PBS Only. Capture antibody: 66756-1-PBS. Detection antibody: 66756-2-PBS. Standard:Ag25746. Range: 3.125-200 ng/mL.

---

Informations sur le produit

66756-1-PBS cible TRAIL/CD253 dans les applications de WB, IHC, Cytometric bead array, Indirect ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Mouse / IgG1
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: TRAIL/CD253 Protéine recombinante Ag25746
• Nom complet: tumor necrosis factor (ligand) superfamily, member 10
• Masse moléculaire calculée: 281 aa, 33 kDa
• Poids moléculaire observé: 28-30 kDa
• Numéro d’acquisition GenBank: BC032722
• Symbole du gène: TRAIL
• Identification du gène (NCBI): 8743
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par protéine G
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

TNFSF10/TRAIL (tumor necrosis factor superfamily member 10) is a typical death ligand expressed on natural killer cells and cytotoxic T lymphocytes. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. TNFSF10 induces apoptotic cell death in cancer by binding to its functional death receptors, death receptor (DR) 4 (TNFRSF10A/TRAIL-R1) and DR5 (TNFRSF10B/TRAIL-R2) to activate the extrinsic apoptosis pathway. TRAIL also activates c-Jun N-terminal kinase (MAPK8/JNK) and the transcription factor nuclear factor-κB (NFκB). The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3.

{{ptg:RelatedPrimaryAntibodies}}